Entry |
|
Symbol |
BCL3
|
Name |
B-cell CLL/lymphoma 3 protein
|
Pathway |
map04625 | C-type lectin receptor signaling pathway |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09130 Environmental Information Processing
09132 Signal transduction
04668 TNF signaling pathway
K09258 BCL3; B-cell CLL/lymphoma 3 protein
09150 Organismal Systems
09151 Immune system
04625 C-type lectin receptor signaling pathway
K09258 BCL3; B-cell CLL/lymphoma 3 protein
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors
K09258 BCL3; B-cell CLL/lymphoma 3 protein
03110 Chaperones and folding catalysts
K09258 BCL3; B-cell CLL/lymphoma 3 protein
Transcription factors [BR:ko03000]
Eukaryotic type
beta-Scaffold factors with minor groove contacts
RHR (Rel homology region) Ankyrin only
K09258 BCL3; B-cell CLL/lymphoma 3 protein
Chaperones and folding catalysts [BR:ko03110]
Other chaperones and cochaperones
Others
K09258 BCL3; B-cell CLL/lymphoma 3 protein
|
Genes |
» show all
|
Reference |
|
Authors |
Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R |
Title |
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. |
Journal |
|
Reference |
|
Authors |
Ohno H, Takimoto G, McKeithan TW |
Title |
The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. |
Journal |
|
Sequence |
|
LinkDB |
|